PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION
Clinical trials for PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION trials appear
Sign up with your email to follow new studies for PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell therapy shows promise for Tough-to-Treat lupus and scleroderma
Disease control Recruiting nowThis study is testing a new treatment using specially engineered immune cells (CAR T cells) from donated cord blood for people with severe lupus, scleroderma, or Sjogren's syndrome that hasn't improved with standard treatments. The main goal is to check if the therapy is safe and…
Matched conditions: PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
Engineered immune cells target three tough autoimmune diseases
Disease control Recruiting nowThis study tests a new treatment using a patient's own immune cells, modified to target and destroy harmful cells in three severe autoimmune conditions: lupus nephritis, systemic sclerosis, and Sjogren's syndrome with pulmonary hypertension. About 45 adults will receive a single …
Matched conditions: PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC